A detailed history of First Trust Advisors LP transactions in Alkermes Plc. stock. As of the latest transaction made, First Trust Advisors LP holds 1,781,135 shares of ALKS stock, worth $52.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,781,135
Previous 1,538,112 15.8%
Holding current value
$52.8 Million
Previous $37.1 Million 34.49%
% of portfolio
0.05%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.01 - $28.55 $5.59 Million - $6.94 Million
243,023 Added 15.8%
1,781,135 $49.9 Million
Q2 2024

Aug 13, 2024

BUY
$23.21 - $27.24 $1.51 Million - $1.78 Million
65,244 Added 4.43%
1,538,112 $37.1 Million
Q1 2024

May 13, 2024

SELL
$26.4 - $32.56 $4.7 Million - $5.8 Million
-178,172 Reduced 10.79%
1,472,868 $39.9 Million
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $3.82 Million - $4.68 Million
163,251 Added 10.97%
1,651,040 $45.8 Million
Q3 2023

Nov 13, 2023

SELL
$27.17 - $31.97 $6.41 Million - $7.54 Million
-235,780 Reduced 13.68%
1,487,789 $41.7 Million
Q2 2023

Aug 14, 2023

SELL
$28.34 - $33.63 $5.58 Million - $6.62 Million
-196,950 Reduced 10.26%
1,723,569 $53.9 Million
Q1 2023

May 15, 2023

SELL
$25.31 - $29.02 $2.24 Million - $2.57 Million
-88,426 Reduced 4.4%
1,920,519 $54.1 Million
Q4 2022

Feb 09, 2023

BUY
$21.94 - $26.24 $7.04 Million - $8.42 Million
320,970 Added 19.02%
2,008,945 $52.5 Million
Q3 2022

Nov 14, 2022

SELL
$22.0 - $31.87 $3.23 Million - $4.69 Million
-147,014 Reduced 8.01%
1,687,975 $37.7 Million
Q2 2022

Aug 12, 2022

SELL
$26.4 - $30.54 $5.43 Million - $6.28 Million
-205,595 Reduced 10.08%
1,834,989 $54.7 Million
Q1 2022

May 13, 2022

SELL
$23.07 - $27.99 $1 Million - $1.22 Million
-43,424 Reduced 2.08%
2,040,584 $53.7 Million
Q4 2021

Feb 08, 2022

SELL
$21.47 - $32.08 $13.6 Million - $20.2 Million
-631,186 Reduced 23.25%
2,084,008 $48.5 Million
Q3 2021

Nov 15, 2021

SELL
$23.37 - $32.13 $10.2 Million - $14 Million
-436,095 Reduced 13.84%
2,715,194 $83.7 Million
Q2 2021

Aug 16, 2021

SELL
$18.78 - $25.15 $2.16 Million - $2.9 Million
-115,128 Reduced 3.52%
3,151,289 $77.3 Million
Q1 2021

May 14, 2021

SELL
$18.21 - $23.2 $11.1 Million - $14.2 Million
-610,157 Reduced 15.74%
3,266,417 $61 Million
Q4 2020

Feb 02, 2021

BUY
$15.39 - $22.1 $1.2 Million - $1.72 Million
77,794 Added 2.05%
3,876,574 $77.3 Million
Q3 2020

Nov 05, 2020

SELL
$16.16 - $20.66 $3.19 Million - $4.08 Million
-197,498 Reduced 4.94%
3,798,780 $62.9 Million
Q2 2020

Jul 22, 2020

BUY
$13.31 - $19.41 $13.9 Million - $20.2 Million
1,040,851 Added 35.22%
3,996,278 $77.5 Million
Q1 2020

May 06, 2020

BUY
$13.06 - $21.24 $2 Million - $3.25 Million
153,087 Added 5.46%
2,955,427 $42.6 Million
Q4 2019

Feb 03, 2020

BUY
$17.29 - $21.74 $3.36 Million - $4.23 Million
194,365 Added 7.45%
2,802,340 $57.2 Million
Q3 2019

Nov 04, 2019

SELL
$19.51 - $24.28 $4.48 Million - $5.58 Million
-229,795 Reduced 8.1%
2,607,975 $50.9 Million
Q2 2019

Jul 30, 2019

SELL
$21.47 - $37.33 $1.48 Million - $2.58 Million
-69,090 Reduced 2.38%
2,837,770 $64 Million
Q1 2019

May 09, 2019

BUY
$28.4 - $36.49 $18.6 Million - $23.9 Million
655,873 Added 29.14%
2,906,860 $106 Million
Q4 2018

Feb 07, 2019

BUY
$27.94 - $44.61 $1.53 Million - $2.45 Million
54,853 Added 2.5%
2,250,987 $66.4 Million
Q3 2018

Oct 25, 2018

BUY
$38.6 - $46.12 $34 Million - $40.7 Million
881,946 Added 67.11%
2,196,134 $93.2 Million
Q2 2018

Aug 02, 2018

BUY
$40.56 - $51.36 $16 Million - $20.2 Million
393,772 Added 42.78%
1,314,188 $54.1 Million
Q1 2018

Apr 23, 2018

BUY
$53.61 - $67.26 $6.42 Million - $8.05 Million
119,664 Added 14.94%
920,416 $53.3 Million
Q4 2017

Feb 08, 2018

BUY
$47.69 - $55.39 $5.98 Million - $6.94 Million
125,309 Added 18.55%
800,752 $43.8 Million
Q3 2017

Oct 24, 2017

BUY
$49.16 - $54.45 $33.2 Million - $36.8 Million
675,443
675,443 $34.3 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.